Financial Performance - The company's revenue for Q1 2025 was ¥412,207,153.06, a decrease of 16.47% compared to ¥493,477,236.15 in the same period last year[5] - Net profit attributable to shareholders increased by 94.77% to ¥76,842,993.90 from ¥39,453,145.75 year-on-year[5] - Basic and diluted earnings per share rose by 97.28% to ¥0.3196 from ¥0.1620 in the same period last year[5] - Operating profit increased to ¥95,150,713.22, up from ¥45,019,532.92, showing a growth of 111.2%[21] - Net profit for the current period is ¥79,983,826.62, compared to ¥43,198,884.56 in the previous period, reflecting an increase of 84.9%[21] - The total comprehensive income for the period was CNY 79,983,826.62, compared to CNY 43,198,884.56 in the previous period, an increase of 84.9%[22] Cash Flow - The net cash flow from operating activities decreased by 21.31% to ¥119,968,984.45 compared to ¥152,458,017.58 in the previous year[5] - Cash inflows from operating activities totaled CNY 409,176,315.44, compared to CNY 514,198,099.43 in the previous period, a decline of 20.4%[25] - The net cash flow from investment activities was negative at -¥82,182,789.07, a decrease of 174.94% compared to the previous year, driven by increased project construction expenditures[9] - The cash and cash equivalents at the end of the period amounted to CNY 979,292,106.38, down from CNY 1,405,025,200.37, a decrease of 30.3%[26] - The company reported a cash outflow from financing activities of CNY -25,909,736.84, an improvement from CNY -65,752,968.18 in the previous period[26] Operating Costs and Expenses - The company's operating costs decreased by 33.02% to ¥253,574,167.95 from ¥378,590,426.71 year-on-year, attributed to product structure optimization[9] - Total operating costs decreased to ¥322,268,648.10 from ¥455,072,945.15, representing a reduction of 29.1%[21] - Research and development expenses decreased by 45.72% to ¥11,601,743.51 from ¥21,374,827.73 in the previous year, mainly due to the completion of certain R&D projects[9] - The income tax expense surged by 850.52% to ¥14,877,021.22 from ¥1,565,137.65 in the same period last year, primarily due to increased corporate income tax provisions[9] - The company paid CNY 22,867,275.68 in taxes, a decrease from CNY 39,222,151.10 in the previous period, reflecting a reduction of 41.6%[25] Shareholder Information - Total number of common shareholders at the end of the reporting period is 20,526[11] - The largest shareholder, Shenzhen Jianyin Wealth Investment Holdings Co., Ltd., holds 11.82% of shares, totaling 28,800,000 shares[11] - The top 10 shareholders collectively hold a significant portion of shares, with the first five shareholders accounting for approximately 42.38% of total shares[11] - The total number of restricted shares at the end of the period is 117,448,750, with no shares released during the current period[13] - The company maintains a strong relationship among major shareholders, indicating a unified action strategy[11] Product Development and Certifications - The company announced that its product 2'-fucosyllactose (2'-FL) has received Self-GRAS certification in the U.S.[14] - The company has ongoing product development, including the certification of lactose-N-tetraose (LNT) through Self-GRAS in the U.S.[15] - The company completed a share repurchase program, with details announced on March 3, 2025[15] - There were no changes in the number of shares lent or returned by major shareholders due to margin trading activities[12] - The company has a clear timeline for the release of restricted shares, with the first batch set to be released on November 25, 2026[13] Assets and Liabilities - Total assets at the end of the reporting period were ¥5,958,974,814.44, a slight increase of 0.37% from ¥5,936,966,199.18 at the end of the previous year[5] - Total liabilities decreased to ¥2,204,960,925.51 from ¥2,257,873,523.38, a reduction of 2.3%[20] - Total equity increased to ¥3,754,013,888.93 from ¥3,679,092,675.80, reflecting a growth of 2.0%[20] - Cash and cash equivalents at the end of the period are ¥1,019,112,530.43, up from ¥1,004,518,191.99 at the beginning of the period, indicating a growth of 1.5%[18] - Accounts receivable increased to ¥463,718,530.29 from ¥451,968,966.69, a rise of 2.0%[18] - Inventory increased to ¥75,126,345.90 from ¥59,719,225.77, representing a growth of 25.7%[18]
朗坤环境(301305) - 2025 Q1 - 季度财报